Evidence map›Paper›PMID 29379013›Full record

ArticleScientific reports2018

Effects of Distal Mutations on the Structure, Dynamics and Catalysis of Human Monoacylglycerol Lipase.

Sergiy Tyukhtenko, Girija Rajarshi, Ioannis Karageorgos, Nikolai Zvonok, Elyssia S Gallagher, Hongwei Huang, Kiran Vemuri, Jeffrey W Hudgens, Xiaoyu Ma, Mahmoud L Nasr and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Journal of chemical information and modeling · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Leveraging intrinsic flexibility to engineer enhanced enzyme catalytic activity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sergiy TyukhtenkoCenter for Drug Discovery and Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115-5000, USA. s.tyukhtenko@northeastern.edu.
Girija RajarshiCenter for Drug Discovery and Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115-5000, USA.
Ioannis KarageorgosBioProcess Measurements Group, Biomolecular Measurement Division, National Institute of Standards & Technology, Rockville, MD, 20850, USA.
Nikolai ZvonokCenter for Drug Discovery and Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115-5000, USA.
Elyssia S GallagherBioProcess Measurements Group, Biomolecular Measurement Division, National Institute of Standards & Technology, Rockville, MD, 20850, USA.ORCID http://orcid.org/0000-0002-5411-7285
Hongwei HuangSchrödinger, 222 Third Street Suite 2230, Cambridge, MA, 02142, USA.
Kiran VemuriCenter for Drug Discovery and Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115-5000, USA.
Jeffrey W HudgensBioProcess Measurements Group, Biomolecular Measurement Division, National Institute of Standards & Technology, Rockville, MD, 20850, USA.ORCID http://orcid.org/0000-0003-2805-1048
Xiaoyu MaCenter for Drug Discovery and Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115-5000, USA.
Mahmoud L NasrDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, 02115, USA.
Spiro PavlopoulosCenter for Drug Discovery and Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115-5000, USA.
Alexandros MakriyannisCenter for Drug Discovery and Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115-5000, USA. a.makriyannis@northeastern.edu.

Funding

MOLECULAR BASIS OF CANNABINOID ACITIVITYR37DA003801 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI MAKRIYANNIS, ALEXANDROS · 1997 to 2006
$3.7M
NIDA NIH HHS R37 DA003801
6 · The paper itself

Abstract

An understanding of how conformational dynamics modulates function and catalysis of human monoacylglycerol lipase (hMGL), an important pharmaceutical target, can facilitate the development of novel ligands with potential therapeutic value. Here, we report the discovery and characterization of an allosteric, regulatory hMGL site comprised of residues Trp-289 and Leu-232 that reside over 18 Å away from the catalytic triad. These residues were identified as critical mediators of long-range communication and as important contributors to the integrity of the hMGL structure. Nonconservative replacements of Trp-289 or Leu-232 triggered concerted motions of structurally distinct regions with a significant conformational shift toward inactive states and dramatic loss in catalytic efficiency of the enzyme. Using a multimethod approach, we show that the dynamically relevant Trp-289 and Leu-232 residues serve as communication hubs within an allosteric protein network that controls signal propagation to the active site, and thus, regulates active-inactive interconversion of hMGL. Our findings provide new insights into the mechanism of allosteric regulation of lipase activity, in general, and may provide alternative drug design possibilities.

Indexed as

Mutation, MissenseAllosteric RegulationAmino Acid SubstitutionDNA Mutational AnalysisHumansModels, MolecularMonoacylglycerol LipasesMutant ProteinsProtein ConformationMonoacylglycerol LipasesMutant Proteins

Identifiers

PMID29379013
PMCPMC5789057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.